Buprenorphine-induced pupillary effects in human volunteers. 1990

W B Pickworth, and H Lee, and P J Fudala
National Institute on Drug Abuse, Addiction Research Center, Baltimore, Maryland 21224.

The pupillary effects of the partial opiate agonist buprenorphine were studied in 16 male subjects who were heroin dependent at the time of admission to the study. Sublingual buprenorphine (8 mg) was administered daily for 18 days and continued either daily or on alternate days from study days 19 through 36. On days 37 through 56, all subjects received buprenorphine placebo. Compared to placebo, buprenorphine decreased pupil size and diminished the constriction and dilation velocities of the light reflex. These effects occurred within 5 hours of buprenorphine administration. Following placebo administration during alternate-day dosing of buprenorphine, pupil size increased and constriction and dilation velocities of the light reflex were significantly greater than after buprenorphine administration in the same subjects. This pattern of effects was observed after buprenorphine was discontinued (day 37). The results indicated that buprenorphine has pupillary effects like those of full opiate agonists. The time course of these effects was similar to previously-reported effects of buprenorphine on the electroencephalogram but not to the time course of subjective effects.

UI MeSH Term Description Entries
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011680 Pupil The aperture in the iris through which light passes. Pupils
D002047 Buprenorphine A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. 6029-M,Buprenex,Buprenorphine Hydrochloride,Buprex,Prefin,RX-6029-M,Subutex,Temgesic,Temgésic,6029 M,6029M,Hydrochloride, Buprenorphine,RX 6029 M,RX6029M
D006556 Heroin Dependence Strong dependence or addiction, both physiological and emotional, upon HEROIN. Heroin Abuse,Heroin Addiction,Heroin Smoking,Abuse, Heroin,Addiction, Heroin,Dependence, Heroin,Heroin Smokings,Smoking, Heroin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W B Pickworth, and H Lee, and P J Fudala
February 1997, Psychopharmacology,
W B Pickworth, and H Lee, and P J Fudala
September 1987, Anesthesia and analgesia,
W B Pickworth, and H Lee, and P J Fudala
January 1990, NIDA research monograph,
W B Pickworth, and H Lee, and P J Fudala
July 2004, Anesthesia and analgesia,
W B Pickworth, and H Lee, and P J Fudala
July 2008, Basic & clinical pharmacology & toxicology,
W B Pickworth, and H Lee, and P J Fudala
February 1995, The Journal of pharmacology and experimental therapeutics,
W B Pickworth, and H Lee, and P J Fudala
December 1989, Methods and findings in experimental and clinical pharmacology,
W B Pickworth, and H Lee, and P J Fudala
June 1992, The Journal of pharmacology and experimental therapeutics,
W B Pickworth, and H Lee, and P J Fudala
January 2016, American journal of therapeutics,
Copied contents to your clipboard!